CME Matters presents


www.LearningProstate.com

Program Description:

In this case-based program, four leading experts in the treatment of prostate cancer will discuss the implications of biochemical recurrence on the clinical management of advanced disease. Join them as they provide insight on the role of androgen deprivation for biochemical and clinical recurrence and discuss steps to improve physician/patient communication and quality of care.

Release Date

January 9, 2007; Review date January 1, 2008; Valid for credit through January 1, 2009

Target Audience:

The target audience for this CME initiative is intended for Urologists, Uro-Oncologist, Medical Oncologists, Radiation Oncologists and other healthcare professionals that deal with patients with prostate cancer.

Learning Objectives:

Credit Available

The American Academy of CME designates this educational activity for a maximum of one AMA PRA Category 1 Credit.™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Accreditation

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the American Academy of CME and NAME. The American Academy of CME, Inc ., is accredited by the ACCME to provide continuing medical education for physicians.

Viewing Requirements

Viewing the CME program requires version 6.x browsers or higher from Microsoft or Netscape or Mozilla FireFox version 1.5.x or higher. Certain activities may require additional software to view multimedia (Macromedia Flash), Audio (mp3 player), or presentation or printable (Adobe Acrobat) versions of their content. There are no specific hardware requirements.